Here we present the cases of two refractory MG patients, one with AChR-IgG and the other with MuSK-IgG, who received anti-BCMA CAR T cells (ClinicalTrials.gov, number NCT04561557). This evidence concerns the gene TNFRSF17 and myasthenia gravis.